Stonepine Capital Management, LLC 13D and 13G filings for Yumanity Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-11 6:22 pm Sale |
2021-12-31 | 13G | Yumanity Therapeutics, Inc. YMTX |
Stonepine Capital Management, LLC | 0 0.000% |
-91,946![]() (Position Closed) |
Filing |
2021-11-19 4:55 pm Purchase |
2021-11-10 | 13G | Yumanity Therapeutics, Inc. YMTX |
Stonepine Capital Management, LLC | 91,946 6.200% |
91,946![]() (New Position) |
Filing |